{
  "id": 5214991,
  "title": "Insmed director Sharoky sells $637,650 of Insmed stock",
  "url": "https://urgent.news/2026/09/03/insmed-director-sharoky-sells-637-650-of-insmed-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-03T01:16:05.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/insmed-director-sharoky-sells-637650-of-insmed-stock-93CH-4886917"
  },
  "original_language": "en",
  "account": "Melvin Sharoky, a Director of Insmed Inc (INSM), disposed of 5,000 shares of the company's stock on August 17, 2026. The shares were sold at prices between $127.51 and $127.61, generating a total sale value of $637,650. This insider sale of common stock by Dr. Sharoky occurred despite the company's analysts maintaining a strong buy consensus with price targets indicating a 56% potential upside. Even after this transaction, Dr. Sharoky holds 246,081 shares directly and has indirect beneficial ownership of additional shares via various entities and accounts, including 6,847 shares held by his spouse and shares held as custodian for several individuals. Despite recent news highlighting Insmed's robust financial performance, with significant revenue increases from its lung-disease drugs BRINSUPRI and ARIKAYCE, leading to a raise in the company's full-year sales outlook for 2026, some analysts still perceive the stock as overvalued based on Fair Value estimates.",
  "summary": null,
  "key_points": [
    "Insmed director Sharoky sold 5,000 shares on August 17, 2026",
    "Shares sold for $637,650 between $127.51 and $127.61 per share",
    "Dr. Sharoky retains 246,081 shares directly, plus indirect ownership"
  ],
  "editors_take": "The sale of Insmed stock by a director despite a strong buy consensus and significant revenue increases suggests some insiders may be taking a cautious view on the stock's valuation.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}